Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Erbitux
Erbitux Image

Erbitux

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Erbitux?

Erbitux, also known by its generic name cetuximab, is a prescription medication primarily used in the treatment of specific types of colorectal cancer. It belongs to a class of drugs called monoclonal antibodies. This medication works by targeting and binding to a protein called epidermal growth factor receptor (EGFR), which is found on the surface of cancer cells. By binding to this receptor, Erbitux inhibits the signals that promote the growth and division of cancer cells. This interference helps slow down or stop the growth of tumors. Erbitux is typically used in combination with other chemotherapy medications or radiation therapy. It may be prescribed for both newly diagnosed and advanced colorectal cancer cases. In some instances, it may also be used for other types of cancer, such as head and neck cancer. It's essential to note that Erbitux has potential side effects, including skin reactions, infusion reactions, diarrhea, and low levels of magnesium and calcium in the blood. It is crucial to discuss any possible risks and benefits with the prescribing healthcare provider before starting this medication. Regular follow-up appointments and monitoring are generally necessary for patients receiving Erbitux treatment.

How to use Erbitux?

Erbitux is a prescription medication that is used to treat specific types of colorectal cancer. It contains the active ingredient cetuximab, which belongs to a class of medications called monoclonal antibodies. Erbitux is typically administered through an intravenous infusion, meaning it is delivered directly into a vein. The dosage and duration of treatment will vary depending on factors such as the patient's weight, overall health, and the specific type and stage of cancer being treated. The medication is usually given in a healthcare setting, such as a hospital or clinic, by a trained healthcare professional. It is important to follow the healthcare provider's instructions carefully and to never self-administer this medication. Prior to receiving Erbitux, patients may be given premedication to help prevent certain side effects, such as allergic reactions. The infusion process usually takes a few hours, and patients are typically monitored closely during and after the administration of the medication. It's essential to communicate any concerns or questions to the healthcare provider, as they can provide personalized guidance and support throughout the treatment process.

Erbitux, also known by its generic name cetuximab, is a prescription medication used in the treatment of certain types of colorectal cancer. Before considering the use of Erbitux, it is essential to be aware of the associated warnings and precautions. One of the primary warnings is the possibility of severe allergic reactions. Some individuals may experience symptoms such as difficulty breathing, rash, itching, swelling, or dizziness. In case of such reactions, immediate medical attention should be sought. Another important warning is the potential for infusion reactions during or after the administration of Erbitux. Symptoms of infusion reactions may include fever, chills, difficulty breathing, low blood pressure, or chest pain. It is crucial to inform healthcare providers about any previous hypersensitivity reactions before receiving Erbitux. Erbitux has also been linked to skin conditions such as acne-like rash, dry skin, and skin infections. Patients should be monitored for any changes in their skin and report them to their healthcare provider. Moreover, Erbitux can cause electrolyte imbalances, which may lead to complications. It is recommended to monitor electrolyte levels and manage any imbalances accordingly. Lastly, Erbitux may interact with other medications, so it is important to provide a comprehensive list of all medications, including over-the-counter drugs and supplements, to the healthcare provider. By familiarizing oneself with these warnings and discussing any concerns with a healthcare provider, patients can make informed decisions about the use of Erbitux in the treatment of colorectal cancer.

Before taking Erbitux, it is important to be aware of several warnings and precautions: 1. Hypersensitivity Reactions: Erbitux can cause severe allergic reactions, including anaphylaxis. It is essential to inform your healthcare provider if you have a history of allergies or have experienced any allergic reactions to medications in the past. 2. Infusion Reactions: During and after the infusion of Erbitux, infusion-related reactions may occur. These reactions can include fever, chills, difficulty breathing, low blood pressure, and rash. Your healthcare provider will closely monitor you during the infusion to manage any potential reactions. 3. Skin Reactions: Erbitux can cause skin reactions, including a rash, itching, redness, dryness, and acne-like breakouts. Inform your healthcare provider if you experience any skin changes while taking this medication. 4. Cardiopulmonary Reactions: Erbitux may cause cardiopulmonary reactions, such as heart attack, congestive heart failure, or pulmonary embolism. Inform your doctor promptly if you experience symptoms such as chest pain, shortness of breath, or swelling of the ankles. 5. Gastrointestinal Perforation: There have been rare cases of gastrointestinal perforation while taking Erbitux. Symptoms may include severe abdominal pain, fever, and chills. Inform your healthcare provider immediately if you experience any of these symptoms. 6. Eye Disorders: Erbitux can cause eye disorders, such as dry eyes, sensitivity to light, and blurred vision. Inform your healthcare provider if you experience any changes in your vision. 7. Pregnancy and Breastfeeding: Erbitux can harm an unborn baby, so it is important to use effective contraception during treatment and avoid becoming pregnant. It is also not recommended to breastfeed while receiving Erbitux. These are some of the important warnings associated with Erbitux. It is crucial to discuss any concerns or potential risks with your healthcare provider before starting this medication.

Erbitux, also known by its generic name cetuximab, is a prescription medication primarily used to treat certain types of colorectal cancer. While it is an effective treatment option, it is important to be aware of potential side effects that may occur. Common side effects of Erbitux include skin rash, itching, dryness, and acne-like eruptions. These skin-related side effects are often manageable with medication or other interventions. Other common side effects may include headache, nausea, diarrhea, and fatigue. It's important to note that Erbitux may also cause more serious side effects, albeit less commonly. These can include severe allergic reactions, difficulty breathing, low magnesium levels, and infection. Additionally, in rare cases, Erbitux can affect the heart, liver, and respiratory system. It is crucial to discuss any concerns or side effects with your healthcare provider promptly. They can provide guidance, monitor your progress, and suggest appropriate measures to manage any adverse reactions. Following your doctor's instructions and reporting any unexpected symptoms is essential for the safe and effective use of Erbitux.

The active ingredient in Erbitux is cetuximab, which is a monoclonal antibody. Cetuximab is a laboratory-made protein that specifically targets and binds to a protein called epidermal growth factor receptor (EGFR), which is found on the surface of certain cancer cells. In addition to cetuximab, Erbitux contains other inactive ingredients that help to formulate the medication into a usable form. These inactive ingredients may vary depending on the specific formulation of Erbitux but could include substances like sodium chloride, polysorbate 80, and water for injection. It's important to note that Erbitux is a prescription medication and should only be used under the guidance and supervision of a healthcare professional experienced in the treatment of cancer.

Erbitux is a prescription medication primarily used to treat specific types of colorectal cancer. Proper storage of Erbitux is essential to maintain its effectiveness and ensure patient safety. Erbitux should be stored in its original packaging at a controlled room temperature between 68°F and 77°F (20°C and 25°C). It is crucial to protect the medication from excessive heat, moisture, and direct sunlight. Avoid storing it in the bathroom or any area prone to humidity. Additionally, Erbitux should be kept out of reach of children and pets, as it is a potent medication that should only be used under medical supervision. If you have any concerns about the storage or handling of Erbitux, consult with your healthcare provider or pharmacist for specific guidance. They can provide you with the necessary information to ensure proper storage and maximize the effectiveness of this medication.